Global Aggregometer Market Share Will Reach to USD 570 Million by 2026: Facts & Factors

[195+ Pages Research Report] According to the recent research report; the global Aggregometer Market in 2019 was approximately USD 360 Million. The market is expected to surge at a CAGR of 6.7% and is anticipated to surpass USD 570 Million by 2026. Top market players in the market are Bio/Data Corporation, Siemens Healthineers AG, Chronolog Corporation, Sysmex Corporation, Helena Laboratories, Tem Group, Perfusion, WerfenLife, S.A., Hart Biologicals and others.


New York, NY, April 26, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Aggregometer Market By Type (Iimpedance Whole Blood Aggregometry, Light Transmission Aggregometry (LTA), Lumi-Aggregometry, Flow-Cytometry, and Others), By Application (Clinical Applications, and Research Applications), By End-Use (Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Blood Banks, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”.

“According to the research report, the global Aggregometer Market was estimated at USD 360 Million in 2019 and is expected to reach USD 570 Million by 2026. The global Aggregometer Market is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2019 to 2026”.

Aggregometer Market: Key Market Insights Overview

Since the twentieth century, the aggregometer, also known as a platelet aggregation method, has been used to calculate the role of platelets. Platelets are involved in blood coagulation and wound healing, which is achieved by a process known as platelet aggregation. In thrombotic, vascular ischemic, and hemorrhagic diseases, platelets are thought to play a role. As a result, anti-platelet therapy (APT) has become the gold standard for multiple cardiovascular diseases, leading to the development of new antiplatelet drugs as well as a number of platelet function tests.

Request Your Free Sample Report of Aggregometer Market @ https://www.fnfresearch.com/sample/aggregometer-market                                      

(The free sample of this report is readily available on request).

Our Free Sample Report Includes:

  • 2020 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 195+ Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of table & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Facts and Factors research methodology

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Key Questions Answered in this Report

1) What were the pre and post-business impacts of COVID-19 on the Aggregometer Market?

2) What is the market size, share of the Aggregometer Market?

3) Who are the top market players in Aggregometer Market?

4) What will be the future market of the Aggregometer Market?

Key Offerings:

  • Market Size & Forecast by Revenue | 2020−2026
  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
  • Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
  • Competitive Landscape – Top key vendors and other prominent vendors

Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/aggregometer-market                                   

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Aggregometer Market: Industry Major Market Players

  • Bio/Data Corporation
  • Chronolog Corporation
  • Helena Laboratories
  • Perfusion
  • Hart Biologicals
  • Alpha Laboratories
  • Instrumentation Laboratory
  • Biola
  • WerfenLife
  • S.A.F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Tem Group
  • Sysmex Corporation
  • Haemonetics Corporation
  • Drucker Diagnostics

To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/aggregometer-market        

The aggregometer market is segmented in terms of type, application, and end-use. Based on the product type, the market is divided into flow-cytometry, impedance whole blood aggregometry, lumi-aggregometry, light transmission aggregometry (LTA), and others. LTA is the gold standard approach for measuring platelet function among these. LTA is the most often used screening procedure for platelet activity abnormalities and antiplatelet therapy control. Based on the application, the market is split into research applications and clinical applications. The segment of clinical applications is anticipated to hold the largest market share as for decades, the aggregometer has become the most widely used equipment in clinical laboratories as a powerful analytical instrument. It can be used to assess the inhibitory and excitatory effects of drugs on platelets and to measure the efficacy of antiplatelet therapy drugs in subjects. It's also used in in vitro experiments to assess platelet activity in human samples before they're put into clinical trials.

Aggregometers with several test modes are available on the market. The number of individual measurements that can be run at the same time is equivalent to the total range of systems in an aggregometer. Any of the aggregometer on the market do not only detect platelet function but also diagnose the sample for von Willebrand's disease. On the basis of end-user analysis, the market is bifurcated into research and academic institutes, standalone hospitals, blood banks, diagnostic laboratories, and others. The standalone hospitals' segment had the largest market share and is projected to continue to do so throughout the estimated period. This high percentage is attributed to an increase in the number of hospitals in developing countries, the public and private investments in healthcare infrastructure growth and modernization, and increased use of platelet function testing in pre-and perioperative hemostasis and transfusion medicine. In the hospital's clinical laboratory, screening procedures such as Visco-elastometry are used to assess the severity of a blood clot. Furthermore, rising surgeon understanding of the benefits of platelet function testing and technical advances in platelet aggregation technologies, the patient use of innovative platelet aggregation devices, and rising surgical procedures are both driving demand for these devices in hospitals.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/aggregometer-market

Global Aggregometer Market: COVID-19 Impact Analysis

Due to the higher number of procedures performed in the region, North America is expected to dominate the global platelet aggregometer market in terms of revenue. Due to the higher adoption of the platelet aggregometer in the area for various test evaluations, Europe is projected to be the second most lucrative market. However, growing evidence of COVID 19's impact on platelet aggregation has led to an increase in research studies on the process.

To Know Analysis on COVID-19 Pre and Post Business Impact, Request a Free Report PDF Brochure: https://www.fnfresearch.com/sample/aggregometer-market

The global burden of cardiac mortality is rising due to an increase in the prevalence of heart attacks such as stroke and coronary heart disease, which has fueled the development of the aggregometer industry. Cardiovascular disease, for example, is identified as the underlying cause of death in the American Heart Association Research Report 2018, accounting for almost 836,546 deaths in the United States. This equates to nearly one in every three deaths in the world. Every day, almost 2,300 Americans die from cardiovascular disease, which equates to one death every 38 seconds. The dramatic growth in the number of people diagnosed with heart diseases fuels the market over the projected timeframe by increasing the use of aggregometer to research platelet aggregation worldwide.

The most effective method for diagnosing platelet defects is light transmission aggregometry (LTA). Furthermore, LTA necessitates a broad sampling volume, and analytical variables have an effect on LTA effects. As a result of both of these influences in conventional aggregometry, aggregometry techniques have developed and advanced, and are now commonly used in the sector. As a result, both of these innovations have been shown to increase penetration rates, thus aiding business development. Furthermore, trained technicians who can standardize, use, and modify procedures are needed for the commercial implementation of emerging technology used in care, research and development, and diagnosis. Any improvement in technique necessitates the use of professional technicians. As a result of a scarcity of qualified specialists to manage emerging technology or products, the market is expected to face growth challenges during the forecast era.

Request Customized Copy of Report @ https://www.fnfresearch.com/customization/aggregometer-market

(We customize your report according to your research need. Ask our sales team for report customization.)

Global Aggregometer Market: Regional Analysis

Due to the higher number of procedures performed in the region, North America is expected to dominate the global platelet aggregometer market in terms of revenue. Due to the higher adoption of the platelet aggregometer in the area for various test evaluations, Europe is projected to be the second most lucrative market. The platelet aggregometer market in Latin America is expected to develop steadily over the forecast period, owing to the platelet aggregometer's growing adoption. With rapidly rising product penetration, Asia-Pacific is expected to be the fastest-growing market. Because of the low acceptance of the product and low test volume in the field, MEA is the least profitable platelet aggregometer sector.

Browse the full “Aggregometer Market By Type (Iimpedance Whole Blood Aggregometry, Light Transmission Aggregometry (LTA), Lumi-Aggregometry, Flow-Cytometry, and Others), By Application (Clinical Applications, and Research Applications), By End-Use (Standalone Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Blood Banks, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at https://www.fnfresearch.com/aggregometer-market

This report segments the aggregometer market as follows:

Global Aggregometer Market: By Type Segmentation Analysis:

  • Flow-Cytometry
  • Impedance Whole Blood Aggregometry
  • Lumi-Aggregometry
  • Light Transmission Aggregometry (LTA)
  • Others

Global Aggregometer Market: By Application Segmentation Analysis

  • Research Applications
  • Clinical Applications

Global Aggregometer Market: By End-Use Segmentation Analysis

  • Research and Academic Institutes
  • Standalone Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market

Related Reports:

Animal Health Market: https://www.fnfresearch.com/animal-health-market

Breast Cancer Treatment Market: https://www.fnfresearch.com/breast-cancer-treatment-market

Adult Day Care Services Market: https://www.fnfresearch.com/adult-day-care-services-market

Pulse Oximeters Market: https://www.fnfresearch.com/pulse-oximeters-market

Fabry Disease Treatment Market: https://www.fnfresearch.com/fabry-disease-treatment-market  

About Facts & Factors (FnF Research):

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us Twitter: https://twitter.com/fnfresearch

Contact Us:

Facts & Factors

USA: +1-347-989-3985

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com


GlobeNewswire